{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T15:58:32Z","timestamp":1753891112240,"version":"3.41.2"},"reference-count":12,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,5,5]],"date-time":"2025-05-05T00:00:00Z","timestamp":1746403200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["24K11003, 22K07887"],"award-info":[{"award-number":["24K11003, 22K07887"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Hyper IgM syndrome (HIGM) is a rare immunodeficiency caused by impaired immunoglobulin class switching, leading to recurrent infections. The present report describes the case of an 18-year-old man initially diagnosed with common variable immunodeficiency at 3 years of age. Genetic analysis revealed a hemizygous <jats:italic>CD40LG<\/jats:italic> missense variant (p.Arg203Ile) associated with X-linked HIGM (XHIGM). Structural and flow cytometric analyses indicated normal CD40 ligand (CD40L) expression on activated CD4<jats:sup>+<\/jats:sup> T-cells but impaired CD40 binding, indicating disrupted immune signaling. Notably, the patient experienced neither bacterial infections requiring hospitalization nor opportunistic infections during 15 years of immunoglobulin replacement therapy. These findings indicate that the p.Arg203Ile variant destabilizes CD40L\u2013CD40 interactions without affecting CD40L expression, suggesting a hypomorphic phenotype. This report highlights the importance of combining genetic testing with functional analysis when evaluating atypical XHIGM presentations to predict clinical severity and provide a scientific basis for personalized treatment strategies. Additional studies are required to assess the long-term outcomes and potential curative therapies for similar cases.<\/jats:p>","DOI":"10.3389\/fimmu.2025.1572791","type":"journal-article","created":{"date-parts":[[2025,5,5]],"date-time":"2025-05-05T05:10:36Z","timestamp":1746421836000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Case Report: CD40LG Arg203Ile variant underlies atypical phenotype of X-linked hyper IgM syndrome"],"prefix":"10.3389","volume":"16","author":[{"given":"Takuro","family":"Nishikawa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dan","family":"Tomomasa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsushi","family":"Hijikata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Kasabata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuhiro","family":"Okamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hans D.","family":"Ochs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hirokazu","family":"Kanegane","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2025,5,5]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.clim.2018.11.007","article-title":"The hyper IgM syndromes: Epidemiology, pathogenesis, clinical manifestations, diagnosis and management","volume":"198","author":"Yazdani","year":"2019","journal-title":"Clin Immunol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaip.2016.09.013","article-title":"Clinical phenotypes of hyper-IgM syndromes","volume":"4","author":"de la Morena","year":"2016","journal-title":"J Allergy Clin Immunol Pract"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2014.05.001","article-title":"A novel disease-causing CD40L mutation reduces expression of CD40 ligand, but preserves CD40 binding capacity","volume":"153","author":"G\u00fcnaydin","year":"2014","journal-title":"Clin Immunol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gki387","article-title":"The FoldX web server: An online force field","volume":"33","author":"Schymkowitz","year":"2005","journal-title":"Nucleic Acids Res"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1093\/bioinformatics\/btt691","article-title":"mCSM: Predicting the effects of mutations in proteins using graph-based signatures","volume":"30","author":"Pires","year":"2014","journal-title":"Bioinformatic"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2003-12-4420","article-title":"Molecular analysis of a large cohort of patients with the hyper immunoglobulin M (IgM) syndrome","volume":"105","author":"Lee","year":"2005","journal-title":"Blood"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1007\/s10875-007-9089-8","article-title":"Clinical follow-up of 11 Argentinian CD40L-deficient patients with 7 unique mutations including the so-called \u201cmilder\u201d mutants","volume":"27","author":"Danielian","year":"2007","journal-title":"J Clin Immunol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.840767","article-title":"Variants disrupting CD40L transmembrane domain and atypical X-linked hyper-IgM syndrome: A case report with leishmaniasis and review of the literature","volume":"13","author":"Palterer","year":"2022","journal-title":"Front Immunol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2023.109692","article-title":"Advanced computational analysis of CD40LG variants in atypical X-linked hyper-IgM syndrome","volume":"253","author":"Pazhanisamy","year":"2023","journal-title":"Clin Immunol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.adl5815","article-title":"Mechanotransduction governs CD40 function and underlies X-linked hyper-IgM syndrome","volume":"10","author":"Choi","year":"2024","journal-title":"Sci Adv"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2015.02.020","article-title":"Clinical features and hematopoietic stem cell transplantations for CD40 ligand deficiency in Japan","volume":"136","author":"Mitsui-Sekinaka","year":"2015","journal-title":"J Allergy Clin Immunol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2016.07.039","article-title":"Long-term outcomes of 176 patients with X-linked hyper-IgM syndrome treated with or without hematopoietic cell transplantation","volume":"139","author":"de la Morena","year":"2017","journal-title":"J Allergy Clin Immunol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1572791\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,5]],"date-time":"2025-05-05T05:10:37Z","timestamp":1746421837000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1572791\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,5]]},"references-count":12,"alternative-id":["10.3389\/fimmu.2025.1572791"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2025.1572791","relation":{},"ISSN":["1664-3224"],"issn-type":[{"type":"electronic","value":"1664-3224"}],"subject":[],"published":{"date-parts":[[2025,5,5]]},"article-number":"1572791"}}